TIAA CREF INVESTMENT MANAGEMENT LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 199 filers reported holding NEKTAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2019$19,433,000
+51.9%
578,377
+48.6%
0.01%
+40.0%
Q4 2018$12,796,000
-75.6%
389,295
-54.7%
0.01%
-41.2%
Q3 2018$52,406,000
+157.5%
859,674
+106.3%
0.02%
+21.4%
Q2 2018$20,353,000
-70.3%
416,810
-35.3%
0.01%
-69.6%
Q1 2018$68,474,000
+83.3%
644,401
+3.0%
0.05%
+84.0%
Q4 2017$37,355,000
+180.9%
625,499
+12.9%
0.02%
+177.8%
Q3 2017$13,296,000
+18.3%
553,989
-3.7%
0.01%
+12.5%
Q2 2017$11,243,000
-34.8%
575,108
-21.8%
0.01%
-33.3%
Q1 2017$17,253,000
+134.2%
735,117
+22.4%
0.01%
+140.0%
Q4 2016$7,366,000
-23.7%
600,363
+6.8%
0.01%
-16.7%
Q3 2016$9,655,000
+18.8%
561,999
-1.6%
0.01%0.0%
Q2 2016$8,124,000
-0.2%
570,890
-3.5%
0.01%0.0%
Q1 2016$8,138,000
-19.6%
591,820
-1.5%
0.01%
-25.0%
Q4 2015$10,124,000
+51.4%
600,840
-1.5%
0.01%
+60.0%
Q3 2015$6,687,000
-15.3%
610,156
-3.3%
0.01%
-16.7%
Q2 2015$7,894,000
-0.9%
631,041
-12.9%
0.01%0.0%
Q1 2015$7,965,000
-29.5%
724,126
-0.6%
0.01%
-25.0%
Q4 2014$11,296,000
+24.2%
728,756
-3.3%
0.01%
+33.3%
Q3 2014$9,092,000
-7.5%
753,273
-1.7%
0.01%
-14.3%
Q2 2014$9,827,000
+9.1%
766,539
+3.2%
0.01%
+16.7%
Q1 2014$9,004,000
+9.0%
742,913
+2.1%
0.01%0.0%
Q4 2013$8,262,000
+8.1%
727,966
-0.5%
0.01%0.0%
Q3 2013$7,643,000
-10.7%
731,394
-1.3%
0.01%
-14.3%
Q2 2013$8,560,000741,1640.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2016
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders